Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by a highly immunosuppressive tumor microenvironment (TME), dense stromal architecture, and limited response to conventional therapies. This review comprehensive... ...
